Changing What Can Be Changed: Validating Navigation as Essential Care in Modern Oncology Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, offering new hope with improved ...
Tumor expression of cGAS, not STING, negatively impacts on the efficacy of PD-1/L1 inhibitors in non-small cell lung cancer with PD-L1 TPS ≥50. This is an ASCO Meeting Abstract from the 2021 ASCO ...
The risk of major adverse events during the periprocedural period is roughly fourfold higher with CABG surgery than with PCI for left main coronary artery disease, but regardless of the initial ...
Discovery of immune checkpoint inhibitors has revolutionized the therapeutic landscape for the treatment of cancer. Development of immunotherapy for cancer is based on modulation of T cell function ...
The FDA Adverse Event Reporting System (FAERS) contains reports from health care professionals, consumers, and manufacturers on adverse events, serious medication errors, and product quality ...
Adverse drug events are more common in older people with comorbidities, a new study finds. Factors that are independently linked with adverse drug events are being female, taking more drugs daily, ...
Please provide your email address to receive an email when new articles are posted on . The FDA Adverse Event Reporting System will now host daily publications, instead of quarterly. The agency’s goal ...
Objective To identify the optimal dose and type of physical activity to improve functional capacity and reduce adverse events in acutely hospitalised older adults. Design Systematic review and ...
Adverse event rates among hospitalized patients declined significantly from 2010 through 2019 in a large study of medical records for adults admitted for acute myocardial infarction, heart failure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results